Deep Dive: Communications 2020COVID-19 might have forced pharma to finally fully embrace digital comms, but it’s been a steep learning curve Share XDeep Dive: Communications 2020https://pharmaphorum.com/sales-marketing/deep-dive-communications-2020/
Giving the forgotten generation of cancer patients a voiceYoung people with cancer need a “seat at the table”, but instead they are often side-lined and voiceless. Share XGiving the forgotten generation of cancer patients a voicehttps://pharmaphorum.com/views-analysis-patients/giving-the-forgotten-generation-of-cancer-patients-a-voice/
Education as the solution to the rare disease ‘diagnostic odyssey’It took more than a year for Don Legere to receive a diagnosis of scleroderma, a rare disease Share XEducation as the solution to the rare disease ‘diagnostic odyssey’https://pharmaphorum.com/views-analysis-patients/education-as-the-solution-to-the-rare-disease-diagnostic-odyssey-scleroderma/
Dangerous data delays – a real-time problemDelayed clinical trial data delivery is a growing problem for pharmaceutical companies and one that can have catastrophic Share XDangerous data delays – a real-time problemhttps://pharmaphorum.com/r-d/clinical-trial-data-delays-real-time/
3 ways pharma marketers can draw inspiration from digitally-native brandsAs pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can Share X3 ways pharma marketers can draw inspiration from digitally-native brandshttps://pharmaphorum.com/views-and-analysis/3-ways-pharma-marketers-can-draw-inspiration-from-digitally-native-brands/
The future of genomic medicine: can it fulfil its promises?Last week geneticist Dr Charles Steward shared with us his experiences of searching for a genetic cause for Share XThe future of genomic medicine: can it fulfil its promises?https://pharmaphorum.com/views-analysis-patients/the-future-of-genomic-medicine-can-it-fulfil-its-promises/
Is a lack of real-time data holding trials back?It’s 2020 and the digital revolution is well on its way. Yet, for clinical trials worldwide, real-time access Share XIs a lack of real-time data holding trials back?https://pharmaphorum.com/r-d/is-a-lack-of-real-time-data-holding-trials-back/
How companies can encourage more diversity and inclusion in pharmaSeptember is Global Diversity and Inclusion month – David Peacock, managing director of MSD in the UK shares Share XHow companies can encourage more diversity and inclusion in pharmahttps://pharmaphorum.com/views-analysis-patients/how-companies-can-encourage-more-diversity-and-inclusion-in-pharma/
Searching for answers in rare epilepsyGeneticist Dr Charles Steward has spent his career studying the human genome – but his work became much Share XSearching for answers in rare epilepsyhttps://pharmaphorum.com/views-analysis-patients/searching-for-answers-in-rare-epilepsy/
